Daniel J. O'Connor

Insider Reports History

Location
New York, NY
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. O'Connor:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma, Inc. President and CEO, Director Common Stock 0 $0 $9.82 07 Mar 2024 Direct
Ambrx Biopharma, Inc. President and CEO, Director Restricted Stock Units 0 $0 $9.82 07 Mar 2024 Direct
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 0 $0 $3.65 20 Feb 2025 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Common Stock 1,377,598 12 Dec 2022 Indirect
Ambrx Biopharma Inc. President and CEO, Director Stock Option (right to buy) 1,216,500 05 Jul 2023 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Warrant (right to buy) 177,204 12 Dec 2022 Indirect
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 64,242 20 Feb 2025 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 1,750 12 Dec 2022 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Warrant (right to buy) 1,750 12 Dec 2022 Direct
SEELOS THERAPEUTICS, INC. Director Stock Option (right to buy) 1,666 04 Jan 2024 Direct
Ambrx Biopharma, Inc. President and CEO, Director Option to Purchase Common Stock 0 07 Mar 2024 Direct

Insider Reports Filed by Daniel J. O'Connor

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 20 Feb 2025 1 $0 4 Director 24 Feb 2025, 17:06
DMAC DiaMedica Therapeutics Inc. 20 Feb 2025 0 $0 3 Director 24 Feb 2025, 16:54
/report/000095017024028190-o-connor-daniel-j-2024-03-07 Ambrx Biopharma, Inc. 07 Mar 2024 5 $0 4 President and CEO, Director 07 Mar 2024, 17:46
/report/000110465924002383-o-connor-daniel-j-2024-01-04 SEELOS THERAPEUTICS, INC. 04 Jan 2024 1 $0 4 Director 08 Jan 2024, 21:45
/report/000095017023069446-o-connor-daniel-j-2023-12-11 Ambrx Biopharma, Inc. 11 Dec 2023 1 $0 4 President and CEO, Director 11 Dec 2023, 17:15
AMAM Ambrx Biopharma, Inc. 27 Oct 2023 1 -$491,118 4 President and CEO, Director 31 Oct 2023, 17:00
/report/000095017023032232-o-connor-daniel-j-2023-07-05 Ambrx Biopharma Inc. 05 Jul 2023 1 $0 4 President and CEO, Director 07 Jul 2023, 16:06
/report/000120919123026093-o-connor-daniel-j-2023-04-26 Ambrx Biopharma Inc. 26 Apr 2023 1 $0 4 President and CEO, Director 28 Apr 2023, 17:59
/report/000113626123000007-o-connor-daniel-j-2023-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2023 1 $0 4 Director 05 Jan 2023, 18:20
/report/000120919123000422-o-connor-daniel-j-2023-01-01 Ambrx Biopharma Inc. 01 Jan 2023 0 $0 3 President and CEO, Director 03 Jan 2023, 17:35
ZVSA ZyVersa Therapeutics, Inc. 12 Dec 2022 4 $0 4 Director, 10%+ Owner 14 Dec 2022, 18:21
/report/000113626122000249-o-connor-daniel-j-2022-06-01 SEELOS THERAPEUTICS, INC. 01 Jun 2022 1 +$9,789 4 Director 02 Jun 2022, 16:29
ZVSA Larkspur Health Acquisition Corp. 06 Jan 2022 3 $0 4 Chief Executive Officer, Director 10 Mar 2022, 16:31
/report/000113626122000020-o-connor-daniel-j-2022-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2022 1 $0 4 Director 06 Jan 2022, 19:06
ZVSA Larkspur Health Acquisition Corp. 20 Dec 2021 0 $0 3 Chief Executive Officer, Director 20 Dec 2021, 17:23